Published September 6, 2026 | Version v1
Other Open

What is the impact of delays in starting the TC regimen (docetaxel and cyclophosphamide) on outcomes for patients with luminal breast cancer?

Authors/Creators

  • 1. Tripdatabase

Description

No direct evidence for the impact of delays in starting the TC regimen on outcomes for luminal breast cancer exists. General evidence across breast cancer types suggests minimising delays in chemotherapy initiation may benefit survival outcomes.

Files

80103da6-8d3e-4ab7-995e-17f13fbf2d06.pdf

Files (18.5 kB)

Name Size
md5:ccc299710436382854b1a81eb9f670f2
18.5 kB Preview Download

Additional details

Related works

Is identical to
https://www.tripdatabase.com/ask/impact-of-delays-in-tc-regimen-on-luminal-breast-cancer-outcomes-80103da6-8d3e-4ab7-995e-17f13fbf2d06 (URL)